Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era
Zawody narciarskie w Szczyrku
Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma | Journal of Medicinal Chemistry
Frontiers | A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia
Rebecca Silbermann M.D., M.M.S. | OHSU People | OHSU
Rola daratumumabu w leczeniu chorych na nawrotowego i opornego szpiczaka plazmocytowego
IHC-plus™ DDB1 Monoclonal Antibody Mouse anti-Human | LSBio
Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors - ScienceDirect
Aleksander SALOMON-PERZYŃSKI | Medical Doctor | Instytut Hematologii i Transfuzjologii, Warsaw | IHT | Department of Hematology | Research profile
CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma - Publication - Bridge of Knowledge
Diagnostics | Free Full-Text | Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
Diagnostics | Free Full-Text | Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
EHA Library - The official digital education library of European Hematology Association (EHA)
Śląska Izba Lekarska - WYRÓŻNIENIA
Frontiers | Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation
Diagnostics | Free Full-Text | Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
Opieka nad pacjentami hematoonkologicznymi zakażonymi SARS-CoV-2 uczy pokory - Puls Medycyny - pulsmedycyny.pl
Prezentacja programu PowerPoint
Prezentacja programu PowerPoint
Jak leczyć pacjenta z nowo rozpoznaną amyloidozą łańcuchów lekkich pośredniego ryzyka? Rola doksycykliny w terapii amylo
Immunochemotherapy for Richter syndrome: current insights: ImmunoTargets and Therapy: Vol 8
Rebecca Silbermann M.D., M.M.S. | OHSU People | OHSU
Bayesian combination of mechanistic modeling and machine learning (BaM3): improving personalized tumor growth predictions
Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model | SpringerLink
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos | Journal of Medicinal Chemistry
